MOG (35–55)
Brain & neurobiology
PreclinicalIt is an experimental antigen used to induce or study experimental autoimmune encephalomyelitis in susceptible rodents.
Laboratory, computational, ex vivo or animal model research is the main evidence base.
What is MOG (35–55)?
MOG (35–55) is a synthetic peptide antigen derived from myelin oligodendrocyte glycoprotein used to induce or study experimental autoimmune encephalomyelitis in susceptible rodent models; the catalogue entry denotes the research peptide.
Which research context has MOG (35–55) been associated with?
MOG (35–55) is associated with neuroscience research as a synthetic encephalitogenic peptide antigen routinely used to induce or study experimental autoimmune encephalomyelitis in susceptible rodent models of CNS autoimmunity.
What documentation is available for MOG (35–55)?
MOG (35–55): Batch documents are not yet linked on this site. For this synthetic encephalitogenic peptide antigen required evidence includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content and residual solvent/water details; and endotoxin or sterility related information where relevant to animal studies. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for MOG (35–55)?
MOG (35–55): Storage depends on the documented supplied presentation; for this synthetic encephalitogenic peptide antigen verify dry/lyophilised versus solution supply, solvent or buffer composition, concentration, pH sensitivity, container closure compatibility and freeze/thaw behaviour since these affect aggregation, chemical stability and antigen integrity. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.